Table 1.
Baseline characteristics.
| HBOT | Control | P-VALUE | |
|---|---|---|---|
| N | 28 | 28 | |
| Age (Y) | 48.2 ± 10.6 | 48.2 ± 9.5 | 1.000 |
| Males | 15 (53.6) | 7 (25.0) | 0.054 |
| Female | 13 (46.4) | 21 (75.0) | 0.054 |
| BMI (Kg/m2) | 27.0 ± 5.5 | 26.6 ± 5.1 | 0.760 |
| Years of education | 14.7 ± 2.5 | 14.9 ± 4.0 | 0.843 |
| Marital status | |||
| Single | 3 (10.7) | 7 (25.0) | 0.295 |
| Married | 21 (75.0) | 15 (53.6) | 0.162 |
| Divorced | 2 (7.1) | 5 (17.9) | 0.422 |
| Widowed | 2 (7.1) | 1 (3.6) | 1.000 |
| N of children | 2.5 ± 1.3 | 2.1 ± 1.4 | 0.377 |
| Employment status | 3 (10.7) | 3 (10.7) | 1.000 |
| Time from infection (days) | 157.5 ± 74.5 | 171.5 ± 71.1 | 0.482 |
| MoCA - cognitive assessment | 25.9 ± 2.7 | 24.9 ± 3.4 | 0.222 |
| Hospitalized* | 4 (14.3) | 4 (14.3) | 1.000 |
| High risk conditions | |||
| BMI†> 30 | 9 (32.1) | 8 (28.6) | 1.000 |
| Age > 60 Y | 3 (10.7) | 4 (14.3) | 1.000 |
| Cancer | 0 (0.0) | 0 (0.0) | 1.000 |
| Diabetes mellitus | 0 (0.0) | 1 (3.6) | 1.000 |
| Hypertension | 4 (14.3) | 2 (7.1) | 0.669 |
| Heart disease | 1 (3.6) | 1 (3.6) | 1.000 |
| Immune deficiency | 0 (0.0) | 0 (0.0) | 1.000 |
| Asthma | 1 (3.6) | 0 (0.0) | 1.000 |
| Other chronic lung diseases | 0 (0.0) | 0 (0.0) | 1.000 |
| Chronic liver disease | 0 (0.0) | 3 (10.7) | 0.236 |
| Chronic kidney disease | 0 (0.0) | 0 (0.0) | 1.000 |
| Hematologic disease\disorder | 0 (0.0) | 0 (0.0) | 1.000 |
| Chronic neurological impairment\disease | 1 (3.6) | 1 (3.6) | 1.000 |
| Smoking | |||
| Current | 0 (0.0) | 0 (0.0) | 1.000 |
| Previous | 8 (28.6) | 4 (14.3) | 0.329 |
Data presented as n (%); continuous data, mean ± SD; † The body-mass index is the weight in kilograms divided by the square of the height in meters.
* during COVID19 infection; MoCA, Montreal cognitive assessment.